Drugs Begining With“c”
For routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE).
Investigated for use/treatment in angioedema.
Investigated for use/treatment in contraception, HIV infection, and prevention of stdis.
CA4P (Combretastatin)has been shown in the laboratory to shut down the blood supply to tumours. It is one of the first vascular targeting drugs to be tested in patients. This drug was originally isolated from the African Bush Willow. The first studies in patients with this drug were aimed at finding out whether it can be safely given to patients, what side effects it produces and whether it can actually shut down the blood supply to human tumours.
For treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.
For the treatment of hyperprolactinemic disorders, either idiopathic or due to prolactinoma (prolactin-secreting adenomas). May also be used to manage symptoms of Parkinsonian Syndrome as monotherapy during initial symptomatic management or as an adjunct to levodopa therapy during advanced stages of disease.
For the treatment of metastatic medullary thyroid cancer.
Investigated for use/treatment in alzheimer's disease.
For management of fatigue, orthostatic hypotension, and for the short term treatment of apnea of prematurity in infants.
For use in combination treatment of HIV infection (AIDS).
Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.